The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...

Nicole Kleinstreuer, who is leading an NIH effort to reduce the use of animals in research, began thinking about the issue as a toxicologist at the EPA ...

The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, ...

OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a ...

Flexible cystoscopy is the most common office-based procedure performed by urologists to diagnose and treat lower urinary tract conditions.

Elinzanetant was associated with significant reductions in vasomotor symptoms and a favorable safety profile at 1 year among menopausal women.

In late September, the U.S. Food & Drug Administration (“FDA”) issued three draft guidances related to cell and gene therapy (“CGT”) products: (1) Innovative Designs for Clinical Trials of CGT ...

Robust improvement demonstrated across diverse set of clinical measures -- Patient-reported outcomes support clinical meaningfulness of ...

Chandler H. Park, MD, a medical oncologist at Norton Cancer Institute and advisory dean/professor at University of Louisville in Kentucky, discusses the Category 1 treatment options for metastatic ...

Dr. Kates’ experience as chair of the landmark Phase 3 BRIDGE bladder cancer trial and dedication to patient care will be invaluable to the ...